Cresco Labs (CRLBF) Current Assets (2019 - 2026)
Cresco Labs (CRLBF) posted Current Assets of $246.7 million for Q1 2026, down 4.86% on a QoQ basis from $259.3 million in Q4 2025, and down 20.71% year-over-year from $311.1 million in Q1 2025.
Cresco Labs (CRLBF) Current Assets (2019 - 2026) Analysis & Trends
Cresco Labs' Current Assets history runs 8 years deep, the most recent figure standing at $246.7 million for Q1 2026.
- Quarterly Current Assets fell 20.71% year-over-year to $246.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $246.7 million (down 20.71% YoY) and the FY2025 annual result came in at $259.3 million, down 11.89% from the prior year.
- Current Assets was $246.7 million for Q1 2026 at Cresco Labs, down from $259.3 million in the prior quarter.
- Across five years, Current Assets topped out at $399.8 million in Q1 2022 and bottomed at $242.6 million in Q3 2025.
- A 5-year average of $298.1 million and a median of $294.3 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets fell 28.38% — and 2025, when it advanced 15.08%.
- Cresco Labs' Current Assets stood at $326.0 million in 2022, then slipped by 14.71% to $278.1 million in 2023, then advanced by 5.81% to $294.3 million in 2024, then retreated by 11.89% to $259.3 million in 2025, then declined by 4.86% to $246.7 million in 2026.
- Business Quant data shows CRLBF's Current Assets at $246.7 million in Q1 2026, $259.3 million in Q4 2025, and $242.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 246.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 246.67 Mn |
| Dec 31, 2025 | 259.27 Mn |
| Sep 30, 2025 | 242.64 Mn |
| Jun 30, 2025 | 314.61 Mn |
| Mar 31, 2025 | 311.09 Mn |
| Dec 31, 2024 | 294.26 Mn |
| Sep 30, 2024 | 311.92 Mn |
| Jun 30, 2024 | 273.37 Mn |
| Mar 31, 2024 | 285.08 Mn |
| Dec 31, 2023 | 278.09 Mn |
| Sep 30, 2023 | 303.17 Mn |
| Jun 30, 2023 | 265.24 Mn |
| Mar 31, 2023 | 286.32 Mn |
| Dec 31, 2022 | 326.05 Mn |
| Sep 30, 2022 | 355.20 Mn |
| Jun 30, 2022 | 314.32 Mn |
| Mar 31, 2022 | 399.80 Mn |
| Dec 31, 2021 | 421.76 Mn |
| Sep 30, 2021 | 449.05 Mn |
| Mar 31, 2021 | 381.69 Mn |